2003
Reduced glutamate neurotransmission in patients with Alzheimer's disease–an in vivo 13C magnetic resonance spectroscopy study
Lin AP, Shic F, Enriquez C, Ross BD. Reduced glutamate neurotransmission in patients with Alzheimer's disease–an in vivo 13C magnetic resonance spectroscopy study. Magnetic Resonance Materials In Physics, Biology And Medicine 2003, 16: 29-42. PMID: 12695884, DOI: 10.1007/s10334-003-0004-x.Peer-Reviewed Original ResearchConceptsN-acetyl aspartateGlutamate neurotransmissionAlzheimer's diseaseCognitive impairmentAD patientsMagnetic resonance spectroscopy measuresPosterior parietal white matterNeuronal tricarboxylic acid cycleCerebral metabolic rateMagnetic resonance spectroscopy studyAge-matched controlsNAA/CrMyo-inositol ratioCognitive impairment characteristicGlucose oxidationMRS measuresNeuronal integrityNeuronal TCA cycleWhite matterGray matterImpairment characteristicPatientsEnrichment of glutamateGlucose ivPilot study
2002
Tricarboxylic acid cycle of glia in the in vivo human brain
Blüml S, Moreno‐Torres A, Shic F, Nguy C, Ross B. Tricarboxylic acid cycle of glia in the in vivo human brain. NMR In Biomedicine 2002, 15: 1-5. PMID: 11840547, DOI: 10.1002/nbm.725.Peer-Reviewed Original Research
2001
Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy
Lin A, Nguy C, Shic F, Ross B. Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. Toxicology Letters 2001, 123: 169-177. PMID: 11641045, DOI: 10.1016/s0378-4274(01)00396-4.Peer-Reviewed Original ResearchConceptsIntact blood-brain barrierBlood-brain barrierProbable Alzheimer's diseaseMagnetic resonance spectroscopyHuman brainVivo magnetic resonance spectroscopyNeurochemical effectsNormal subjectsNormal volunteersWhite matterAlzheimer's diseaseMethylsulfonylmethaneMemory lossPatientsToxic exposureBrainMedical benefitsResonance spectroscopySubjectsDiseaseDiagnosisDosesDailyVolunteers